Research Progress of Spironolactone as an Antagonist of NRG1-ERBB4 Pathway in the Treatment of Cognitive Impairment in Schizophrenia
Outcomes of a Precision Digital Care Program for Obesity and Associated Comorbidities: Results in Real World Clinical Practice